GBCMY (Global Bio-chem Technology Group Co) Total Liabilities: $660.3 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GBCMY Global Bio-chem Technology Group Co Ltd GBCMY
33 GF Score
Price $4.14
! 5 Warning Signs
View Full Analysis

What is Global Bio-chem Technology Group Co Total Liabilities?

Global Bio-chem Technology Group Co GBCMY 33 Total Liabilities is $660.3 Mil as of Dec. 2025. GuruFocus rates GBCMY with a GF Score™ of 33/100. The stock has 5 warning signs investors should review.

Global Bio-chem Technology Group Co's Total Liabilities for the quarter that ended in Dec. 2025 was $660.3 Mil.

Global Bio-chem Technology Group Co's quarterly Total Liabilities increased from Dec. 2024 ($835.74 Mil) to Jun. 2025 ($878.45 Mil) but then declined from Jun. 2025 ($878.45 Mil) to Dec. 2025 ($660.28 Mil).

Global Bio-chem Technology Group Co's annual Total Liabilities declined from Dec. 2023 ($1,183.90 Mil) to Dec. 2024 ($835.74 Mil) and declined from Dec. 2024 ($835.74 Mil) to Dec. 2025 ($660.28 Mil).

Global Bio-chem Technology Group Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Global Bio-chem Technology Group Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Bio-chem Technology Group Co Total Liabilities Chart

Global Bio-chem Technology Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,690.41 1,751.61 1,183.90 835.74 660.28

Global Bio-chem Technology Group Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,183.90 968.17 835.74 878.45 660.28
GBCMY
33GF Score
Global Bio-chem Technology Group Co Ltd GBCMY
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Bio-chem Technology Group Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Global Bio-chem Technology Group Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=587.091+(71.992+1.192
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=660.3

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=593.633--66.641
=660.3

Global Bio-chem Technology Group Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=587.091+(71.992+1.192
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=660.3

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=593.633--66.641
=660.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $660.3 Mil mean?
Global Bio-chem Technology Group Co (GBCMY) has a Total Liabilities of $660.3 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Global Bio-chem Technology Group Co and its competitors.
Is Global Bio-chem Technology Group Co's Total Liabilities too high?
Global Bio-chem Technology Group Co's current Total Liabilities is $660.3 Mil. Overall, Global Bio-chem Technology Group Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Global Bio-chem Technology Group Co's Total Liabilities compare to KHC and GIS?
Global Bio-chem Technology Group Co's Total Liabilities of $660.3 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Global Bio-chem Technology Group Co and its competitors. Global Bio-chem Technology Group Co's current Total Liabilities is $660.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Bio-chem Technology Group Co stock overvalued right now?
Global Bio-chem Technology Group Co (GBCMY) has a current Total Liabilities of $660.3 Mil. The current Total Liabilities is $660.3 Mil. Global Bio-chem Technology Group Co's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Global Bio-chem Technology Group Co (GBCMY), the current Total Liabilities is $660.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Bio-chem Technology Group Co Business Description

Other Exchanges 00809:Hong KongGLY:Germany
Address The Metropolis Tower, 10 Metropolis Drive, Unit 1206, 12th Floor, Cheung Kei Center, Hung Hom, Kowloon, Hong Kong, HKG
Global Bio-chem Technology Group Co Ltd is engaged in the manufacture and sale of corn refined products and amino acids. The upstream corn refinery serves as a feedstock which breaks down corn kernels into corn starch, gluten meal, fibre and corn oil; and corn starch is further refined through a series of biochemical and/or chemical processes into a wide range of high value-added downstream products. Its segments include the upstream products segment; and the amino acids segment engages in the manufacture and sale of corn based biochemical products, including lysine and threonine. It derives the majority of the revenue from the amino acids segment. Geographically, it operates in The PRC, and Asia, the Americas and other regions.
33GF Score

Get the complete analysis for GBCMY

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.14
Price